Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMC 443394)

Published in J Clin Invest on December 01, 1992

Authors

J A Corbett1, J L Wang, M A Sweetland, J R Lancaster, M L McDaniel

Author Affiliations

1: Department of Pathology, Washington University School of Medicine, Saint Louis 63110.

Articles citing this

Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A (1998) 4.72

Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest (1997) 2.45

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06

Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.94

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes (2010) 1.80

Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol (2017) 1.54

Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med (2005) 1.45

Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40

Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med (1997) 1.33

Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med (1998) 1.30

The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci (2013) 1.30

In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med (1999) 1.25

Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol (2000) 1.17

Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16

Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A (1994) 1.09

Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol (2001) 1.08

Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). Proc Natl Acad Sci U S A (2006) 1.02

On the pathogenesis of IDDM. Diabetologia (1994) 1.02

Role of increased ROS dissipation in prevention of T1D. Ann N Y Acad Sci (2008) 1.01

Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud (2005) 1.01

Pancreatic β-cell death in response to pro-inflammatory cytokines is distinct from genuine apoptosis. PLoS One (2011) 0.99

How the location of superoxide generation influences the β-cell response to nitric oxide. J Biol Chem (2015) 0.99

Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression. J Biol Chem (2009) 0.98

Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J (1994) 0.96

AMP-activated protein kinase attenuates nitric oxide-induced beta-cell death. J Biol Chem (2009) 0.94

Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated β-cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol Metab (2009) 0.94

Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells. Mol Endocrinol (2012) 0.92

Do β-cells generate peroxynitrite in response to cytokine treatment? J Biol Chem (2013) 0.91

FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide. J Biol Chem (2011) 0.90

Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol (1994) 0.89

Differential responses of pancreatic β-cells to ROS and RNS. Am J Physiol Endocrinol Metab (2013) 0.87

Nitric oxide induces ataxia telangiectasia mutated (ATM) protein-dependent γH2AX protein formation in pancreatic β cells. J Biol Chem (2014) 0.83

CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells. Biochim Biophys Acta (2015) 0.82

Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina. ASN Neuro (2015) 0.81

The destructive action of IL-1alpha and IL-1beta in IDDM is a multistage process: evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. Mediators Inflamm (1999) 0.81

IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB. Am J Physiol Endocrinol Metab (2015) 0.81

Low Level Pro-inflammatory Cytokines Decrease Connexin36 Gap Junction Coupling in Mouse and Human Islets through Nitric Oxide-mediated Protein Kinase Cδ. J Biol Chem (2015) 0.81

Myricetin protects against cytokine-induced cell death in RIN-m5f β cells. J Med Food (2012) 0.80

Mitochondrial hormesis in pancreatic β cells: does uncoupling protein 2 play a role? Oxid Med Cell Longev (2012) 0.80

Distinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines. Am J Physiol Regul Integr Comp Physiol (2015) 0.79

Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha. Immunology (2007) 0.78

Regulation of electrolyte transport with IL-1beta in rabbit distal colon. Mediators Inflamm (1995) 0.77

SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β Cell. J Biol Chem (2015) 0.77

Biobreeding rat islets exhibit reduced antioxidative defense and N-acetyl cysteine treatment delays type 1 diabetes. J Endocrinol (2013) 0.77

Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates. J Biol Chem (2016) 0.76

Enhanced MIN-6 beta cell survival and function on a nitric oxide-releasing peptide amphiphile nanomatrix. Int J Nanomedicine (2014) 0.76

Amyloid and the macrophage: it's all about local production of IL-1β. Diabetes (2014) 0.76

Nitric oxide stress and activation of AMP-activated protein kinase impair β-cell sarcoendoplasmic reticulum calcium ATPase 2b activity and protein stability. Cell Death Dis (2015) 0.76

Group VIB Phospholipase A(2) promotes proliferation of INS-1 insulinoma cells and attenuates lipid peroxidation and apoptosis induced by inflammatory cytokines and oxidant agents. Oxid Med Cell Longev (2012) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A (1990) 10.40

Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry (1988) 10.17

L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 6.93

Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes (1965) 6.00

Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci U S A (1991) 4.01

EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A (1990) 2.94

Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76

Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol (1982) 2.54

A new in vitro model for the study of pancreatic A and B cells. Endocrinology (1985) 2.29

Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science (1992) 2.25

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett (1990) 2.14

Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. J Biol Chem (1991) 1.73

L-citrulline production from L-arginine by macrophage nitric oxide synthase. The ureido oxygen derives from dioxygen. J Biol Chem (1990) 1.70

IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem Biophys Res Commun (1990) 1.60

Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem (1991) 1.59

Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54

A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48

Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology (1987) 1.45

Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun (1991) 1.42

Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy (1985) 1.37

Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J (1992) 1.34

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23

Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol (1990) 1.16

Secretagogue-induced oscillations of cytoplasmic Ca2+ in single beta and alpha-cells obtained from pancreatic islets by fluorescence-activated cell sorting. Biochem Biophys Res Commun (1990) 1.06

Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest (1990) 1.02

Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy (1986) 1.02

L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase. Endocrinology (1991) 0.98

An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr Top Microbiol Immunol (1990) 0.97

An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia (1991) 0.96

Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function. Endocrinology (1989) 0.95

The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metab Rev (1987) 0.93

Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta. Diabetologia (1991) 0.90

Insulin-secreting beta-cells possess specific receptors for interleukin-1 beta. FEBS Lett (1990) 0.90

Confocal microscopic analysis of the nonendocrine cellular component of isolated adult rat islets of Langerhans. Transplantation (1991) 0.82

Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified beta-cells. FEBS Lett (1990) 0.79

Articles by these authors

Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci U S A (1973) 5.13

Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci U S A (1973) 4.75

Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ (1998) 4.51

Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature (2001) 3.92

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40

Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics (1994) 3.12

The covalent and three-dimensional structure of concanavalin A. Proc Natl Acad Sci U S A (1972) 3.09

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92

The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A (2001) 2.75

Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73

Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem (1998) 2.66

Unusual fragments in the subunit structure of concanavalin A. Proc Natl Acad Sci U S A (1971) 2.62

Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A (1998) 2.56

The complete amino acid sequence of beta 2-microglobulin. Biochemistry (1973) 2.55

The kinetics of cellular commitment during stimulation of lymphocytes by lectins. J Cell Biol (1974) 2.33

A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci U S A (1986) 2.27

Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A (1995) 2.11

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06

Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes (1992) 2.04

Modulation of lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1975) 2.02

Nitric oxide: a new paradigm for second messengers. J Med Chem (1995) 1.94

Intraocular lens power calculation after laser in situ keratomileusis for myopia and hyperopia: a standardized approach. Cornea (2001) 1.90

Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86

Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem (1998) 1.85

Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes (1999) 1.79

Isolation and proteolytic cleavage of the intact subunit of concanavalin A. Biochemistry (1972) 1.78

Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75

Ionic polysaccharides. 3. Dilute solution properties of hyaluronic acid fractions. Biopolymers (1970) 1.72

Intracellular Ca2+ mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-trisphosphate in isolated pancreatic islets. J Biol Chem (1986) 1.70

Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol (1996) 1.63

Nitrite inhibition of Clostridium botulinum: electron spin resonance detection of iron-nitric oxide complexes. Science (1983) 1.63

Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1978) 1.62

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest (2002) 1.61

Dual modes of aging in Mediterranean fruit fly females. Science (1998) 1.59

Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem (1991) 1.59

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 1.59

Lateral diffusion of phospholipids in the plasma membrane of soybean protoplasts: Evidence for membrane lipid domains. Proc Natl Acad Sci U S A (1986) 1.57

The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1979) 1.57

Internal morphology of human cervical pedicles. Spine (Phila Pa 1976) (2000) 1.57

Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J (2000) 1.55

Isolation and characterization of the iron-containing superoxide dismutase of Methanobacterium bryantii. Arch Biochem Biophys (1981) 1.52

Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol (1989) 1.51

Fasting augments lipid peroxidation during reperfusion after ischemia in the perfused rat liver. Crit Care Med (1999) 1.50

Mortality oscillations induced by periodic starvation alter sex-mortality differentials in Mediterranean fruit flies. J Gerontol A Biol Sci Med Sci (1999) 1.49

A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48

Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes (2001) 1.42

Initiation of replication in chromosomal DNA induced by extracts from proliferating cells. Proc Natl Acad Sci U S A (1976) 1.41

Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem (1995) 1.41

Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab (2001) 1.40

Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40

Antibodies reactive with cell surface carbohydrates. Proc Natl Acad Sci U S A (1975) 1.39

Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci U S A (1987) 1.39

Protest at Nobel omission of Moncada. Nature (1998) 1.38

Kinetics of colchicine inhibition of mitogenesis in individual lymphocytes. Exp Cell Res (1976) 1.38

Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci U S A (1995) 1.37

Relationship of age patterns of fecundity to mortality, longevity, and lifetime reproduction in a large cohort of Mediterranean fruit fly females. J Gerontol A Biol Sci Med Sci (1998) 1.37

The covalent and three-dimensional structure of concanavalin A. III. Structure of the monomer and its interactions with metals and saccharides. J Biol Chem (1975) 1.37

IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry (1993) 1.36

Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J (1992) 1.34

Isolation of lectins of different specificities on a single affinity adsorbent. J Biol Chem (1975) 1.33

Siderophore iron transport followed by electron paramagnetic resonance spectroscopy. J Biol Chem (1982) 1.33

Carbohydrate binding protein 35. Complementary DNA sequence reveals homology with proteins of the heterogeneous nuclear RNP. J Biol Chem (1988) 1.32

Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31

Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest (1999) 1.30

Growth control in cultured 3T3 fibroblasts. Assays of cell proliferation and demonstration of a growth inhibitory activity. J Cell Biol (1979) 1.30

Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int (2000) 1.29

Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun (1993) 1.29

Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem (1999) 1.28

Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res (2001) 1.28

Glucose-induced accumulation of inositol trisphosphates in isolated pancreatic islets. Predominance of the 1,3,4-isomer. Biochem J (1986) 1.25

Conformational changes in concanavalin A. J Biol Chem (1971) 1.24

Fluorescent probes for conformational states of proteins. IV. The pepsinogen-pepsin conversion. J Biol Chem (1971) 1.24

Cyclooxygenase-2 in rat nephron development. Am J Physiol (1997) 1.24

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23

Hyperinsulinism in mice with heterozygous loss of K(ATP) channels. Diabetologia (2006) 1.22

Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol Renal Physiol (2001) 1.22

The covalent and three-dimensional structure of concanavalin A. II. Amino acid sequence of cyanogen bromide fragment F3. J Biol Chem (1975) 1.21

Cloning and analysis of the C4 photosynthetic NAD-dependent malic enzyme of amaranth mitochondria. J Biol Chem (1994) 1.20

Studies of the beta-galactoside transporter in inverted membrane vesicles of Escherichia coli. I. Symmetrical facilitated diffusion and proton gradient-coupled transport. J Biol Chem (1977) 1.20

Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J Biol Chem (1990) 1.18

Early mortality surge in protein-deprived females causes reversal of sex differential of life expectancy in Mediterranean fruit flies. Proc Natl Acad Sci U S A (1997) 1.17

Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol (1997) 1.17

Constitutive expression of cyclooxygenase-2 in rat vas deferens. Am J Physiol (1998) 1.17

Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett (1995) 1.17

Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16

Activation of tumor necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric oxide. J Biol Chem (2000) 1.15

Insulin mediates glucose-stimulated phosphorylation of PHAS-I by pancreatic beta cells. An insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem (1998) 1.15

Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic Biol Med (1999) 1.15